Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Metzger

Showing results (161-170 of 167) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 167 results.
The Journal of Emergency Medicine|March 29, 2011
Excited Delirium Syndrome (ExDS): defining based on a review of the literatureGary M Vilke, Mark L DeBard, Theodore C Chan, et al.
Science Translational Medicine|October 11, 2013
BPIFB1 is a lung-specific autoantigen associated with interstitial lung diseaseAnthony K Shum, Mohammad Alimohammadi, Catherine L Tan, et al.
Nature|July 20, 2018
Thymic tuft cells promote an IL-4-enriched medulla and shape thymocyte developmentCorey N Miller, Irina Proekt, Jakob von Moltke, et al.
Circulation|September 10, 2025
Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK TrialBrian G DeRubertis, Ramon L Varcoe, Prakash Krishnan, et al.
The New England Journal of Medicine|October 27, 2023
Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery DiseaseRamon L Varcoe, Brian G DeRubertis, Raghu Kolluri, et al.
Journal of the American College of Cardiology|May 13, 2026
Long-Term Outcomes of a Drug-Eluting Resorbable Scaffold vs Angioplasty in Infrapopliteal Chronic Limb-Threatening Ischemia: 3-Year Results From the LIFE-BTK TrialSahil A Parikh, Brian G DeRubertis, Marc P Bonaca, et al.
Journal of Medicinal Chemistry|October 26, 2025
Discovery of ORIC-533, an Orally Bioavailable CD73 Inhibitor That Maintains Activity in High AMP Environments to Reverse Tumor ImmunosuppressionJared T Moore, Hiroyuki Kawai, Brian R Blank, et al.
Pageof 17

Showing results (161-170 of 167) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
The Journal of Emergency Medicine|March 29, 2011
Excited Delirium Syndrome (ExDS): defining based on a review of the literatureGary M Vilke, Mark L DeBard, Theodore C Chan, et al.
Science Translational Medicine|October 11, 2013
BPIFB1 is a lung-specific autoantigen associated with interstitial lung diseaseAnthony K Shum, Mohammad Alimohammadi, Catherine L Tan, et al.
Nature|July 20, 2018
Thymic tuft cells promote an IL-4-enriched medulla and shape thymocyte developmentCorey N Miller, Irina Proekt, Jakob von Moltke, et al.
Circulation|September 10, 2025
Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK TrialBrian G DeRubertis, Ramon L Varcoe, Prakash Krishnan, et al.
The New England Journal of Medicine|October 27, 2023
Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery DiseaseRamon L Varcoe, Brian G DeRubertis, Raghu Kolluri, et al.
Journal of the American College of Cardiology|May 13, 2026
Long-Term Outcomes of a Drug-Eluting Resorbable Scaffold vs Angioplasty in Infrapopliteal Chronic Limb-Threatening Ischemia: 3-Year Results From the LIFE-BTK TrialSahil A Parikh, Brian G DeRubertis, Marc P Bonaca, et al.
Journal of Medicinal Chemistry|October 26, 2025
Discovery of ORIC-533, an Orally Bioavailable CD73 Inhibitor That Maintains Activity in High AMP Environments to Reverse Tumor ImmunosuppressionJared T Moore, Hiroyuki Kawai, Brian R Blank, et al.
Pageof 17